title: Outcome predictors for intestinal Behçet's disease.
abstract: Behçet's disease (BD) is a multisystem inflammatory disorder that presents as recurrent oral and genital ulcers in conjunction with other dermatological and ocular manifestations. The prevalence of BD is higher in Middle and East Asia than in Western countries. Intestinal BD is a specific subtype of BD, characterized by intestinal ulcers and associated gastrointestinal symptoms. Similar to inflammatory bowel disease, intestinal BD exhibits a fluctuating disease course with repeated episodes of relapse and remission that necessitate adequate maintenance therapy after achievement of clinical remission. Medical treatment of intestinal BD is largely empirical since well-controlled studies have been difficult to perform due to the heterogeneity and rarity of the disease. To date, 5-aminosalicylic acid, systemic corticosteroids, and immunosuppressants have been used anecdotally to treat intestinal BD. The clinical course of intestinal BD shows considerable variability, and the exact point at which more potent agents such as immunosuppressants should be used has not yet been elucidated. Given the difficulty in predicting which patients will experience complicated disease courses and the fact that these drugs are related with certain risk resulting from immunosuppression, proper identification of prognostic factors in intestinal BD may allow physicians to implement tailored medical therapy and individualized patient monitoring based on risk stratification. In this review, the impact of baseline characteristics on the long-term course of intestinal BD, prognostic factors during various medical therapies, and outcome predictors related to surgery will be discussed.
authors.affiliation: Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. geniushee@yuhs.ac.
authors.forename: Jae Jun
authors.initials: JJ
authors.lastname: Park
authors.forename: Won Ho
authors.initials: WH
authors.lastname: Kim
authors.forename: Jae Hee
authors.initials: JH
authors.lastname: Cheon
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D001528:Behcet Syndrome / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007167:Immunotherapy; D007410:Intestinal Diseases / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D008297:Male; D011379:Prognosis; D012737:Sex Factors
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents
keywords: Intestinal Behçet’s disease; medical treatment; prognostic factors; surgical treatment
references.citation: Clin Exp Immunol. 1997 Feb;107(2):241-7
references.pmid: 9030859
references.citation: Semin Arthritis Rheum. 1998 Feb;27(4):197-217
references.pmid: 9514126
references.citation: J Gastroenterol. 2007 Sep;42(9):737-45
references.pmid: 17876543
references.citation: Am J Gastroenterol. 2000 Oct;95(10):2848-51
references.pmid: 11051358
references.citation: Int J Colorectal Dis. 2010 Nov;25(11):1371-6
references.pmid: 20533055
references.citation: Inflamm Bowel Dis. 2008 Sep;14(9):1259-64
references.pmid: 18393375
references.citation: Clin Rheumatol. 2007 Aug;26(8):1383-5
references.pmid: 17039261
references.citation: Gut. 2001 Nov;49(5):725-8
references.pmid: 11600479
references.citation: Dig Dis Sci. 2013 Feb;58(2):496-503
references.pmid: 22899244
references.citation: Gastroenterology. 2001 Mar;120(4):995-9
references.pmid: 11231954
references.citation: Dig Dis Sci. 2011 Mar;56(3):812-8
references.pmid: 20632102
references.citation: Dis Colon Rectum. 2007 May;50(5):672-6
references.pmid: 17216141
references.citation: Inflamm Bowel Dis. 2012 Jun;18(6):1064-71
references.pmid: 21793128
references.citation: Dis Colon Rectum. 2000 May;43(5):692-700
references.pmid: 10826433
references.citation: Am J Gastroenterol. 2003 Mar;98(3):703-4
references.pmid: 12650819
references.citation: N Engl J Med. 1999 Oct 21;341(17):1284-91
references.pmid: 10528040
references.citation: Dig Dis Sci. 2010 Oct;55(10):2904-11
references.pmid: 20094787
references.citation: Inflamm Bowel Dis. 2012 Apr;18(4):750-7
references.pmid: 21618352
references.citation: Dig Dis Sci. 2014 Oct;59(10):2529-35
references.pmid: 24838499
references.citation: Dis Colon Rectum. 2006 Dec;49(12):1849-59
references.pmid: 17080284
references.citation: Am J Gastroenterol. 2009 Oct;104(10):2492-9
references.pmid: 19532129
references.citation: Dig Dis Sci. 2009 Feb;54(2):201-7
references.pmid: 18594975
references.citation: Mod Rheumatol. 2011 Apr;21(2):184-91
references.pmid: 21052764
references.citation: Rev Rhum Engl Ed. 1996 Jul-Sep;63(7-8):512-9
references.pmid: 8896069
references.citation: J Clin Gastroenterol. 2012 May-Jun;46(5):e38-45
references.pmid: 22298088
references.citation: Inflamm Bowel Dis. 2013 Aug;19(9):1833-8
references.pmid: 23702810
references.citation: Semin Arthritis Rheum. 1979 May;8(4):223-60
references.pmid: 382361
references.citation: J Clin Gastroenterol. 2000 Mar;30(2):144-54
references.pmid: 10730919
references.citation: Yonsei Med J. 1997 Dec;38(6):423-7
references.pmid: 9509912
references.citation: J Clin Gastroenterol. 2010 Jul;44(6):e116-22
references.pmid: 20054283
references.citation: Inflamm Bowel Dis. 2011 Jul;17(7):1594-602
references.pmid: 21674717
references.citation: Hum Pathol. 1985 Aug;16(8):790-5
references.pmid: 4018777
references.citation: Dis Colon Rectum. 2003 Jan;46(1):118-21
references.pmid: 12544532
references.citation: Endoscopy. 2000 Aug;32(8):635-40
references.pmid: 10935793
references.citation: Inflamm Bowel Dis. 2001 Aug;7(3):243-9
references.pmid: 11515851
references.citation: Lancet. 1990 May 5;335(8697):1078-80
references.pmid: 1970380
references.citation: Clin Exp Med. 2004 Sep;4(1):10-20
references.pmid: 15598081
references.citation: Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):15-29
references.pmid: 19949430